We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Charles River Laboratories Choses BioTrove OpenArray™ Technology for the Second Time
News

Charles River Laboratories Choses BioTrove OpenArray™ Technology for the Second Time

Charles River Laboratories Choses BioTrove OpenArray™ Technology for the Second Time
News

Charles River Laboratories Choses BioTrove OpenArray™ Technology for the Second Time

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Charles River Laboratories Choses BioTrove OpenArray™ Technology for the Second Time"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

BioTrove has announced that Charles River Laboratories will use the BioTrove OpenArray™ system to detect rodent-specific pathogens as part of their effort to evaluate the health of rodent species.

This is the second OpenArray instrument purchased by Charles River since 2006, when the organization adopted the OpenArray SNP Genotyping System for use in its genetic quality control process.

Charles River Laboratories is designing pathogen panels using OpenArray plates, each of which can contain between 16 and 3072 easily-changed assays and can be loaded with up to 144 samples.

The company says that the OpenArray system’s high-throughput, large-scale PCR screening capabilities permits the detection of infectious agents, while its flexibility in assay panel modification accommodates the addition or modification of assays to include newly-identified strains or species.

Advertisement